Neuracle Technology (Changzhou) Co., Ltd.(Hereinafter referred to as “neuracle”) is a leading global enterprise in brain computer interface(BCI) technology. Neuracle continues to explore and stimulate the brain’s potential and achieve major breakthroughs in the field of BCI. Neuracle has the highest market share in the high-end BCI market in China and maintains rapid growth, making it a leading enterprise in the field of brain computer interfaces in China. Neuracle is a national level specialized and innovative “little giant” enterprise. Neuracle has formed a non-invasive and minimally invasive BCI platform. In terms of non-invasiveness, with the support of the national 12th Five-Year Science and Technology Support Plan, we have adopted a completely independent innovation technology route and developed a number of high-performance EEG acquisition systems for BCI applications, and have obtained 5 national
medical device registrations and dozens of national patent grants. This system has broken the monopoly of imported products from Japan, Europe and the United States for many years, and has been widely used in BCI research and clinical diagnosis and treatment of various neurological and psychiatric diseases. In terms of minimally invasive technology, with the support of the national 13th Five-Year Science and Technology Support Plan and the national “unveiling the list” mission, a coin-sized BCI system is buried in the skull through minimally invasive surgery to transmit and store all EEG data in real time. It is a long-term stable and reliable two-way closed-loop brain-computer interface system. This system will provide a new treatment plan for patients with major mental, neurological, skeletal, and muscular diseases such as epilepsy, progressive freezing, depression, Alzheimer’s disease, complete spinal cord injury, stroke, amyotrophic lateral sclerosis (ALS), and myasthenia gravis.
